Incidence of Cardiovascular Diseases in Patients With Hypopituitarims
NCT00442858 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2007-03-05
Summary
The aim of the present study was therefore two-fold: 1) to make a retrospective comparison of incidence of non-fatal stroke and cardiac events between a large cohort of patients with confirmed GHD on replacement therapy (including GH) and a control cohort from the general population; 2) to compare the prevalence of DM and cardioprotective medication between the cohorts at the time of questionnaire distribution with adjustment for possible confounders and effect modifiers.
Conditions
Sponsors & Collaborators
-
Lund University Hospital
lead OTHER
Principal Investigators
-
Eva Marie T Erfurth, MD, PhD · Endocrine Unit, Department of Medicine, University Hospital, Lund
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-01-31
- Completion
- 2002-12-31
More Related Trials
-
GH and Cardiovascular Risk Factors
NCT01877512 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
NCT00182091 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone's Effect on the Cardiovascular System
NCT00397319 ·Status: TERMINATED
-
Adult Growth Hormone Deficiency and Cardiovascular Risk
NCT00720902 ·Status: TERMINATED ·Phase: PHASE4
-
Growth Hormone in Ischemic Heart Failure
NCT04420481 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients
NCT01562834 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults
NCT01088399 ·Status: COMPLETED
-
Posttraumatic Hypopituitarism - Incidence, Predictors and Test Validity
NCT01028742 ·Status: COMPLETED
-
Effect of 5 Years of GH Replacement on Atherosclerosis
NCT00462475 ·Status: COMPLETED
-
Growth Hormone Deficiency in Chronic Heart Failure: an Observational Study
NCT00511927 ·Status: COMPLETED
-
Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy
NCT00711061 ·Status: COMPLETED
-
Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
NCT01502124 ·Status: COMPLETED ·Phase: PHASE3
-
Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
NCT00136032 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury
NCT00638053 ·Status: TERMINATED ·Phase: PHASE4
-
A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency
NCT00455884 ·Status: COMPLETED
-
An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
NCT01009905 ·Status: COMPLETED
-
Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial
NCT00591760 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Long-term Somatropin Treatment in Adults
NCT01543880 ·Status: COMPLETED
-
Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)
NCT01020955 ·Status: COMPLETED ·Phase: PHASE3
-
Growth Hormone and Endothelial Function in Children
NCT00373386 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Prospective Study on Patients Treated With Norditropin®
NCT00960128 ·Status: COMPLETED
-
Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia
NCT01807364 ·Status: COMPLETED
-
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
NCT00187993 ·Status: UNKNOWN
-
Treatment of GHD Associated With CHF
NCT03775993 ·Status: UNKNOWN ·Phase: PHASE3
-
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
NCT00139945 ·Status: COMPLETED ·Phase: NA